ScholarIQanswers from OpenAlex
Potassium and Related Disorders
TopicLeading institutions, researchers & key papers
Potassium and Related Disorders is a topic indexed in ScholarIQ from OpenAlex.
What is known about Potassium and Related Disorders?
ScholarIQrecord summary
This cluster of papers focuses on the management of hyperkalemia, particularly in patients with kidney diseases. It covers various aspects such as the use of renin-angiotensin-aldosterone system inhibitors, potassium homeostasis, and the effectiveness of treatments like sodium zirconium cyclosilicate and patiromer. Additionally, it explores the association of hyperkalemia with conditions like chronic kidney disease, heart failure, and gastrointestinal adverse events.
How many works does Potassium and Related Disorders have?
ScholarIQindexed works
Potassium and Related Disorders has 253 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Potassium and Related Disorders?
ScholarIQopenalex
The OpenAlex for Potassium and Related Disorders is on the source record.
What are the most-cited papers on Potassium and Related Disorders?
ScholarIQmost cited works
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Rajiv Agarwal, Gerasimos Filippatos, Bertram Pitt, Stefan D. Anker, Peter Rossing, Amer Joseph, Peter Kolkhof, Christina Nowack, Martin Gebel, Luís M. Ruilope, George L. Bakris, FIDELIO-DKD and FIGARO-DKD investigators
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
Matthew R. Weir, George L. Bakris, David A. Bushinsky, Martha Mayo, Dahlia Garza, Yuri Stasiv, Janet Wittes, Heidi Christ‐Schmidt, Lance Berman, Bertram Pitt
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Lisa M. Einhorn, Min Zhan, Van Doren Hsu, Lori D. Walker, Maureen F. Moen, Stephen L. Seliger, Matthew R. Weir, Jeffrey C. Fink
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Catherine M. Clase, Juan Jesús Carrero, David H. Ellison, Morgan E. Grams, Brenda R. Hemmelgarn, Meg Jardine, Csaba P. Kövesdy, Gregory Kline, Gregor Lindner, Gregorio T. Obrador, Biff F. Palmer, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer, Roberto Pecoits‐Filho, Gloria Ashuntantang, Stephan J. L. Bakker, George L. Bakris, Sunil Bhandari, Emmanuel A. Burdmann, Katrina L. Campbell, David M. Charytan, Deborah J. Clegg, Lílian Cuppari, David Goldsmith, Stein Hallan, Jiang He, Charles A. Herzog, Melanie P. Hoenig, Ewout J. Hoorn, Jens Leipziger, Amanda K. Leonberg‐Yoo, Edgar V. Lerma, Jose Ernesto Lopez-Almaraz, Jolanta Małyszko, Johannes F.E. Mann, Matti Marklund, Alicia A. McDonough, Masahiko Nagahama, Sankar D. Navaneethan, Bertram Pitt, Oleh Pochynyuk, Thyago Proença de Moraes, Zubaid Rafique, Bruce Robinson, Simon D. Roger, Patrick Rossignol, Adam J. Singer, Andrew Smyth, Manish M. Sood, Michael Walsh, Matthew R. Weir, Charles S. Wingo
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
Bertram Pitt, Stefan D. Anker, David A. Bushinsky, Dalane W. Kitzman, Faı̈ez Zannad, I‐Zu Huang, on behalf of the PEARL-HF Investigators
Where is Potassium and Related Disorders research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Potassium and Related Disorders is open access?
ScholarIQopen access share
67%OPEN ACCESS